serena williams on glp-1 Opens Up About Being a Serena Williams paid endorsement for

Description

By indication, type 2 diabetes accounted for 87.36% revenue in 2025, but obesity and weight-management prescriptions are forecast to grow at 11.57% CAGR to 2031

Taking off: Massports board signed off yesterday on a $425 million plan to revamp how you get to Logan Airports Terminal E, the primary terminal for international flights

First and foremost, patients on GLP-1 medications need to be at or near their goal weight before considering surgical options

The significantly better weight loss results with tirzepatide (22.5% versus 14.9% average) might be worth the slightly higher side effect risk for many people

The sub-study estimates put the lean-mass share of total weight lost somewhere in the region of 25 to 40 percent, depending on the population, the measurement method, and how the analysis is done